Search Results - "Ronchi, Celestino"

Heparan Sulfate and Enoxaparin Interact at the Interface of the Spike Protein of HCoV-229E but Not with HCoV-OC43 by Fuochi, Virginia, Floresta, Giuseppe, Emma, Rosalia, Patamia, Vincenzo, Caruso, Massimo, Zagni, Chiara, Ronchi, Federica, Ronchi, Celestino, Drago, Filippo, Rescifina, Antonio, Furneri, Pio Maria

“…It is known that the spike protein of human coronaviruses can bind to a secondary receptor, or coreceptor, to facilitate the virus entry. While HCoV-229E uses…”
Get full text

Control of Transdermal Permeation of Hydrocortisone Acetate from Hydrophilic and Lipophilic Formulations by Fini, Adamo, Bergamante, Valentina, Ceschel, Gian Carlo, Ronchi, Celestino, De Moraes, Carlos Alberto Fonseca

“…The purpose of this research was the preparation of four formulations containing hydrocortisone acetate (HCA) for topical application, including two aqueous…”
Get full text

Pharmacokinetic bioequivalence, safety and acceptability of Ornibel®, a new polymer composition contraceptive vaginal ring (etonogestrel/ethinylestradiol 11.00/3.474 mg) compared with Nuvaring® (etonogestrel/ethinylestradiol 11.7/2.7 mg) by Algorta, Jaime, Diaz, Maria, de Benito, Raquel, Lefebvre, Marc, Sicard, Eric, Furtado, Milton, Regidor, Pedro Antonio, Ronchi, Celestino

“…Objective: To show the clinical development of Ornibel ® (ExeltisHealthcare, Spain) a contraceptive vaginal ring manufactured with a new polymer composition…”
Get full text

Fast dispersible/slow releasing ibuprofen tablets by Fini, Adamo, Bergamante, Valentina, Ceschel, Gian Carlo, Ronchi, Celestino, de Moraes, Carlos Alberto Fonseca

“…Eight formulations were developed containing ibuprofen in the form of orally disintegrating tablets. To prevent bitter taste and side effects of the drug, the…”
Get full text

Ophthalmic delivery systems based on drug–polymer–polymer ionic ternary interaction: In vitro and in vivo characterization by Sandri, Giuseppina, Bonferoni, Maria Cristina, Chetoni, Patrizia, Rossi, Silvia, Ferrari, Franca, Ronchi, Celestino, Caramella, Carla

“…Aim of the work was to develop mucoadhesive eyedrops containing tetrahydrozoline hydrochloride (TZ), a decongestant drug, and based on a ternary interaction…”
Get full text

Effect of vehicles on topical application of aloe vera and arnica montana components by Bergamante, Valentina, Ceschel, Gian Carlo, Marazzita, Sergio, Ronchi, Celestino, Fini, Adamo

“…In this study two types of gels and microemulsions are investigated for their ability to dissolve, release, and induce the permeation of helenalin, a flavonoid…”
Get more information

Design and Evaluation In Vitro of Controlled Release Mucoadhesive Tablets Containing Chlorhexidine by Carlo Ceschel, Gian, Bergamante, Valentina, Calabrese, Valeria, Biserni, Stefano, Ronchi, Celestino, Fini, A.

“…ABSTRACT This investigation deals with the development of buccal tablets containing chlorhexidine (CHX), a bis-bis-guanide with antimicrobial and antiseptic…”
Get full text

Solubility and transdermal permeation properties of a dehydroepiandrosterone cyclodextrin complex from hydrophilic and lipophilic vehicles by Ceschel, GianCarlo, Bergamante, Valentina, Maffei, Paola, Lombardi Borgia, Simone, Calabrese, Valeria, Biserni, Stefano, Ronchi, Celestino

“…The permeation ability of a compound is due principally to its concentration in the vehicle and to its aptitude to cross the stratum corneum of the skin. In…”
Get more information

Skin permeation study of dehydroepiandrosterone (DHEA) compared with its alpha-cyclodextrin complex form by Ceschel, Gian Carlo, Mora, Paolo Corvi, Lombardi Borgia, Simone, Maffei, Paola, Ronchi, Celestino

“…Several studies have shown that dehydroepiandrosterone (DHEA) has promising uses in a large range of pathologies including age-related illnesses (osteoporosis,…”
Get more information

The Role of Excipients in the Control of Dehydroepiandrosterone Inclusion Complex Delivery by Bergamante, Valentina, Ceschel, Gian Carlo, Lombardi Borgia, Simone, Ronchi, Celestino, Fini, Adamo

“…Aim: The aim of this study was to develop systems containing dehydroepiandrosterone (DHEA), in the form of an inclusion complex with alpha -cyclodestrin…”
Get full text

Comparative bioavailability of two formulations containing atenolol and chlortalidone associated in a 4 :1 fixed combination by MARZO, Antonio, MONTI, Nunzia Ceppi, BO, Lorenzo Dal, MAZZUCCHELLI, Paolo, CRIVELLI, Fabrizio, TETTAMANTI, Rosella Aleotti, ISMAILI, Shevqet, UHR, Mario Richard, RONCHI, Celestino, PORZIOTTA, Enrico

“…Atenolol (CAS 29122-68-7) and chlortalidone (CAS 77-36-1) are marketed associated in a 4:1 strength ratio (100/25 and 50/12.5 mg) for the treatment of…”
Get full text